Business
PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement
PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc. ("Veris"), today announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), a National Cancer Institute (NCI)-Designated Comprehensi
About this update from Veris Limited
[{"type":"text","content":"The Veris Cancer Care Platform to be deployed to enhance personalized cancer care in patients undergoing systemic cancer therapy across OSUCCC – James","length":150,"tagName":"p","attribs":{}},{"type":"text","content":"NEW YORK, Oct. 7, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc. ("Veris"), today announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), a National Cancer Institute (NCI)-Designated Comprehensive Cancer Center have launched the commercial phase of their long-term strategic partnership agreement.","length":682,"tagName":"p"},{"type":"image","alt":"Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. (PRNewsfoto/PAVmed Inc.)","displaySize":"","headline":null,"caption":"Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices. (PRNewsfoto/PAVmed Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":150,"url":"https://media.zenfs.com/en/prnewswire.com/88f60508f05c1ca5756def4f1f4396b5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/iT3Ww2ZAjzKZmEmDdKJakg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI2NDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/88f60508f05c1ca5756def4f1f4396b5","width":400,"height":150}},"href":"https://mma.prnewswire.com/media/2011715/Veris_Health_Logo_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""We are pleased to move into the commercial phase of our partnership with The James at OSU, one of the largest and most prestigious academic cancer centers in the nation, to expand clinical deployment of our platform to enhance personalized cancer care," said Brian deGuzman,...